🇺🇸 FDA
Patent

US 11208479

CX43 hemichannel antibodies and methods of use

granted A61KA61K49/0008A61P

Quick answer

US patent 11208479 (CX43 hemichannel antibodies and methods of use) held by The Board of Regents of the University of Texas System expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K49/0008, A61P, A61P19/02